Cytokinetics (CYTK) Cash from Operations (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Cash from Operations of 145500000.0 for Q1 2026, down 10.55% year-over-year from 162657121.14 in Q1 2025, and down 2.0% quarter-over-quarter from 142642000.0 in Q4 2025.
Cytokinetics (CYTK) Cash from Operations (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Cash from Operations for 17 consecutive years, with 145500000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 10.55% year-over-year to 145500000.0; the TTM figure through Mar 2026 stood at 523883000.0 (down 31.63% YoY), while the FY2025 annual figure was 510000000.0, down 28.82% from the prior year.
- Cash from Operations eased to 145500000.0 in Q1 2026 per CYTK's latest filing, from 142642000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 26811000.0 in Q1 2022 and bottomed at 145500000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 103837588.24 across 5 years, with a median of 101500000.0 in 2024.
- On a YoY basis, Cash from Operations climbed as much as 24.6% in 2023 and fell as far as 356.1% in 2023.
- Cytokinetics' Cash from Operations stood at 98190000.0 in 2022, then climbed by 24.6% to 74037000.0 in 2023, then climbed by 11.44% to 65570000.0 in 2024, then slumped by 117.54% to 142642000.0 in 2025, then slipped by 2.0% to 145500000.0 in 2026.
- Business Quant data shows CYTK's Cash from Operations at 145500000.0 in Q1 2026, 142642000.0 in Q4 2025, and 107505000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | -159.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -159.80 Mn |
| Jun 30, 2026 | -159.80 Mn |
| Mar 31, 2026 | -145.50 Mn |
| Mar 31, 2026 | -145.50 Mn |
| Dec 31, 2025 | -142.64 Mn |
| Dec 31, 2025 | -142.64 Mn |
| Sep 30, 2025 | -107.51 Mn |
| Sep 30, 2025 | -107.51 Mn |
| Jun 30, 2025 | -128.24 Mn |
| Jun 30, 2025 | -128.24 Mn |
| Mar 31, 2025 | -131.62 Mn |
| Mar 31, 2025 | -131.62 Mn |
| Dec 31, 2024 | -65.57 Mn |
| Dec 31, 2024 | -65.57 Mn |
| Sep 30, 2024 | -101.50 Mn |
| Sep 30, 2024 | -101.50 Mn |
| Jun 30, 2024 | -99.31 Mn |
| Jun 30, 2024 | -99.31 Mn |
| Mar 31, 2024 | -129.51 Mn |
| Mar 31, 2024 | -129.51 Mn |